Company / Total Assets
Altimmune, Inc. Total Assets History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$279.9M
FY2025
5-year range
$139.3M / $279.9M
FY2021-FY2025
Trend
+100.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Total Assets has fluctuated over the past 10 years, ranging from $23M in FY2011 to $280M in FY2025.
Based on SEC 10-K filings.
$280M in FY2025 with a 5-year CAGR of +2.7%.
Improved from $211M to $280M over the past 2 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- +10.6%
- 5-Year CAGR
- +2.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +2.7%, indicating consistent growth.
- In FY2025, total assets increased 100.9% year-over-year.
- Lowest total assets in the period was in FY2011.
Company context
Key Data Points
- Altman Z-Score -0.62 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $279.9M | +100.9% |
| FY2024 | $139.3M | -33.9% |
| FY2023 | $210.6M | +1.8% |
| FY2022 | $206.9M | -5.5% |
| FY2021 | $218.9M | -10.7% |
| FY2020 | $245.1M | +353.4% |
| FY2019 | $54.1M | -1.3% |
| FY2018 | $54.8M | -13.1% |
| FY2017 | $63.0M | +176.4% |
| FY2011 | $22.8M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026